A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom-Reference-Cited by-同舟云学术

A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom

Published:2023-09-11 Issue:1 Volume:22 Page:785-800
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Campling James¹,Vyse Andrew¹,Liu Hui-Hsuan²,Wright Hannah¹,Slack Mary³,Reinert Ralf-Rene⁴,Drayson Mark⁵,Richter Alex⁵,Singh Dave⁶,Barlow Gavin⁷,Kassianos George⁸⁹,Ellsbury Gillian¹

Affiliation:

1. Medical Affairs, Pfizer Ltd, Walton Oaks, UK

2. Real-World Evidence, OPEN Health, London, UK

3. School of Medicine & Dentistry, Griffith University, Southport, Queensland, Australia

4. Medical Affairs, Pfizer Inc, Pfizer, Paris, France

5. Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, UK

6. Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK

7. Hull York Medical School, University of York, York, UK

8. Royal College of General Practitioners, London, UK

9. British Global & Travel Health Association, Bath, UK

Funder

Hui-Hsuan Liu at OPEN Health and was funded by Pfizer

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2256394

Reference131 articles.

1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019. 2019. [cited 2022 December 02]. Available from: https://www.who.int/publications/i/item/10665-310968

3. UK Health Security Agency. Pneumococcal: the Green Book chapter 25. 2020 [cited2022 August 01]. Available from: https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25

4. Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England

5. Increasing Hospital Admissions for Pneumonia, England

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Vaccines for Chronic Respiratory Patients;Archivos de Bronconeumología;2024-09

2. Uptake and safety of pneumococcal vaccination in adults with immune-mediated inflammatory diseases: a UK wide observational study;Rheumatology;2024-03-13

3. Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniae in older adults: a narrative review;Current Opinion in Infectious Diseases;2024-02-06

4. A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide;Clinical and Experimental Vaccine Research;2024

5. Multifaceted Analysis of Preferences and Drivers for Adult Vaccination Clinic Site Selection: A Cross-Sectional Study;2024